Austrian Biotech Themis Launches Zika Vaccine Clinical Trial Austrian Biotech Themis Launches Zika Vaccine Clinical Trial

Austrian biotech company Themis Bioscience said on Tuesday it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news